# Myopharm Limited jobs and careers

> 0 open roles at Myopharm Limited as of October 24, 2026. Source: https://www.thejobsmap.com/company/myopharm-limited

Myopharm is an IND stage biotechnology company focused on developing first in class, novel therapeutics for the treatment and prevention of Type 2 diabetes. Myopharm is currently developing a number of diabetes therapeutics including a beta-cell-centric dual combination drug, to address the 50% antidiabetic treatment failures occurring in Type 2 diabetics. Right now, there are no anti-inflammatory 'Beta-cell-centric' therapies on the market for Type 2 diabetes. Our novel & innovative beta-cell centric product, RK-01 or TriGlytza™ restored the efficacy of Metformin in C57BL/6J DIO mice with insulin resistance and pancreatic beta-cell dysfunction. We are on track to bring TriGlytza™ to market by 2027. https://www.myopharm.com

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Founded | 2020 |
| Employees | 11 to 50 |
| Industries | Biotechnology, Health Care, Therapeutics, Diabetes |
| Website | https://myopharm.com |

## Leadership

- Charles Czank, Head of Clinical Development
- Advait Padhye, Research Associate

## Common questions

### Is Myopharm Limited hiring right now?

Myopharm Limited has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Myopharm Limited's careers site.

### Who leads Myopharm Limited?

Charles Czank, Head of Clinical Development, is at the top of Myopharm Limited's org chart.

### How do I apply for a job at Myopharm Limited?

Pick a role on Myopharm Limited's TheJobsMap page and select Apply. Every listing links to the original posting on Myopharm Limited's own careers site, so you apply directly with the employer.